Opinion: Out With the Old

The research community doesn’t need more journals. It’s time we embrace non-traditional publishing platforms.

Written byViviane Callier
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WIKIMEDIA, BRIAN108 (LEFT); SWTPC6800 (RIGHT)It used to be that the only way a scientist could keep up with the latest research in her field was to read printed papers published in the journals that she or her institution had subscribed to. Then came the Internet. Compared with other communities, the scientific enterprise was slow to embrace the digital dissemination of information. Eventually, most journals appeared online.

During the transition to this new world of advanced access and online firsts, more and more scientists began blogging and participating in crowdsourced commentary. Today, many stakeholders agree that the publishing system ought to be replaced with a more efficient and transparent platform: one that benefits both authors and readers. But before we can improve upon the existing formula, we must assess its utility.

Scholarly journals serve two major functions: curation and dissemination. Under the current framework, the curatorial function that journal editors and peer reviewers fulfill is considered problematic by many scientists: there is often tremendous disagreement among editors and reviewers about what constitutes a sufficiently “significant” advance to warrant publication in a specific journal1. Acceptance of a given manuscript largely reflects a value ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Viviane was a Churchill Scholar at the University of Cambridge, where she studied early tetrapods. Her PhD at Duke University focused on the role of oxygen in insect body size regulation. After a postdoctoral fellowship at Arizona State University, she became a science writer for federal agencies in the Washington, DC area. Now, she freelances from San Antonio, Texas.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies